semaglutide for alcohol rebound The Department of Veterans Affairs on Thursday announced a clinical trial to test whether injectable semaglutide, a GLP-1 drug widely prescribed diabetes and weight loss can also treat abuse, a A U.S. study involving 503,747

A separate meta-analysis of randomized trials and observational studies found lower alcohol-related events among GLP-1 users, including among patients with alcohol use disorder

Stick around as we answer your pressing questions, debunk the myths, and uncover the science-backed reality

Lennox et al., 2014)

Yet many people struggle to drink enough throughout Build Healthy Habits Most people dont struggle with knowing what to dothey struggle with doing it consistently

Dr Hungerford says we need more long-term, large-scale studies to see how these medications impact people living with eating disordersincluding what happens when they stop using them as weight gain can be triggering for someone experiencing, or at risk of developing, an eating disorder